261780 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
CHA Vaccine Research Institute Co., Ltd. operates as a research-oriented biotechnology company. The firm involves in research and development of vaccine products targeting infectious disease as well as chronic disease. It specializes in proprietary vaccine adjuvant L-pampo and recombinant antigen development platform. The company was founded by Hong Mo Moon on June 13, 2000 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
261780 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company